Treating Allergic Cough in Children

Allergic cough in children is a common clinical presentation characterized by persistent, dry, non-productive coughing triggered by exposure to environmental allergens such as dust mites, pollen, mold spores, or pet dander. Unlike infectious or post-viral coughs, allergic cough typically lacks systemic symptoms like fever or malaise and often follows a circadian pattern—worsening at night or upon waking—and may be associated with other atopic features including allergic rhinitis, conjunctivitis, or eczema.

Diagnosis hinges on a detailed history, physical examination, and targeted testing. Clinicians assess temporal associations between cough onset and allergen exposure, evaluate for personal or family history of atopy, and rule out alternative causes—including asthma, gastroesophageal reflux disease (GERD), upper airway cough syndrome (UACS), and chronic infections. Skin prick testing or serum-specific IgE assays help identify sensitization, while pulmonary function testing with bronchial challenge may be indicated if underlying asthma is suspected.

Management follows a stepwise, multimodal approach. First-line intervention emphasizes allergen avoidance—using high-efficiency particulate air (HEPA) filters, encasing mattresses and pillows in allergen-impermeable covers, reducing indoor humidity to inhibit dust mite proliferation, and limiting pet exposure where relevant. Pharmacotherapy includes second-generation oral antihistamines (e.g., cetirizine or loratadine) for mild cases, and intranasal corticosteroids for concomitant allergic rhinitis. In persistent or moderate-to-severe presentations, inhaled corticosteroids (ICS) are often prescribed—even in the absence of classic asthma—given their efficacy in reducing airway inflammation and cough reflex hypersensitivity.

For children with confirmed IgE-mediated allergy and recurrent, refractory symptoms despite optimal pharmacologic and environmental control, allergen immunotherapy (AIT) may be considered. Sublingual or subcutaneous AIT has demonstrated long-term benefits in reducing cough frequency, medication dependence, and risk of asthma progression. Close monitoring by a pediatric allergist or pulmonologist is essential throughout treatment, with regular reassessment of symptom control, inhaler technique, and adherence to avoid undertreatment or unnecessary escalation.